SI
SYNDEVRX INC
SEC filingBiotechnology · Cambridge, MA
Amount raised$6.5Msold at filing
Total offering$20M$13.5M still open
Investors in the raise7count reported to the SEC
FiledDec 23, 2025first sale Nov 4, 2024
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Bradley J CarverExecutive Officer, Director
David Michael NeafusExecutive Officer
Charles Michael FlynnDirector
Jeffrey Michael WellesDirector
James Michael ShanahanExecutive Officer, Director
Michael Michael CliffordDirector
Executive officers, directors and promoters as listed on the Form D.